Neurocritical care and target immunotherapy for febrile infection-related epilepsy syndrome

Biomed J. 2020 Jun;43(3):205-210. doi: 10.1016/j.bj.2020.03.009. Epub 2020 Apr 21.

Abstract

Febrile infection-related epilepsy syndrome (FIRES) is an intractable neurological disease characterized by an unexplained refractory status epilepticus triggered by febrile infection. A Consensus definition of FIRES was proposed in 2018, and its clinical features and prognosis are gradually being clarified. However, the development of effective treatments has been hindered as the etiology of this rare disease is as yet unelucidated. The basic approach to the management of FIRES, like other forms of epilepsy, is based on the control of seizures, however seizures are extremely intractable and require intravenous administration of large doses of anticonvulsants, mainly barbiturates. This treatment strategy produces various complications including respiratory depression and drug hypersensitivity syndrome, which make it more difficult to control seizures. Consequently, it is crucial to predict these events and to formulate a planned treatment strategy. As well, it is important to grow out of conventional treatment strategies that rely on only anticonvulsants, and alternative therapies are gradually being developed. One such example is the adoption of a ketogenic diet which may lead to reduced convulsions as well as improve intellectual prognosis. Further, overproduction of inflammatory cytokines in the central nervous system has been shown to be strongly related to the pathology of FIRES which has led to attempts at immunomodulation therapy including anti-cytokine therapy.

Keywords: Anti-cytokine therapy; Burst-suppression coma; Febrile infection-related epilepsy syndrome (FIRES); Ketogenic diet; New-onset refractory status epilepticus (NORSE).

Publication types

  • Review

MeSH terms

  • Anticonvulsants / therapeutic use
  • Epileptic Syndromes* / etiology
  • Epileptic Syndromes* / therapy
  • Fever / etiology*
  • Humans
  • Immunotherapy
  • Infections / complications*
  • Seizures / drug therapy

Substances

  • Anticonvulsants